Please provide your email address to receive an email when new articles are posted on . The FDA approval was based on pharmacokinetic and pharmacodynamic data. The 375 health care providers surveyed ...
Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. A major advantage of using JAK inhibitors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback